NCT04263623View on ClinicalTrials.gov

Clinical Study to Assess the Efficacy and Safety of AT-5214 in the Treatment of Subjects With Palmar Hyperhidrosis

PHASE2UnknownINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

January 31, 2020

Primary Completion Date

December 3, 2020

Study Completion Date

September 30, 2021

Conditions
HyperhidrosisPalmar Hyperhidrosis
Interventions
DRUG

Dexmecamylamine HCl

Investigational drug

OTHER

Placebo

Oral tablet containing no active drug.

Trial Locations (1)

23502

Site 01, Norfolk

Sponsors
All Listed Sponsors
lead

Atacama Therapeutics

INDUSTRY

NCT04263623 - Clinical Study to Assess the Efficacy and Safety of AT-5214 in the Treatment of Subjects With Palmar Hyperhidrosis | Biotech Hunter | Biotech Hunter